HomeInsightsMarket Capitalization

Market Capitalization of Piramal Pharma Ltd

Market Capitalization of Piramal Pharma Ltd

stocks purchased

₹ 3.9 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

132.1 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

MARKETCAP

₹ 38725.1 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Piramal Pharma Ltd is ₹ 38725 crore as of 07 Nov 24.
  • The Market Cap of Piramal Pharma Ltd changed from ₹ 8165 crore on March 2023 to ₹ 17052 crore on March 2024 . This represents a CAGR of 44.51% over 2 years. .
  • The Latest Trading Price of Piramal Pharma Ltd is ₹ 293.5 as of 08 Nov 10:18.
  • The Dividend Payouts of Piramal Pharma Ltd is ₹ 0.11 as of Jul 12, 2024.

Historical Market Cap of Piramal Pharma Ltd

No data available

* All values are in crore

Company Fundamentals for Piramal Pharma Ltd

No data available

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

PRICE

₹ 293.5

1.40 (0.48%)

stock direction

Last updated on: Nov 08 10:18 AM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024292.1
06 Nov 2024293.55
05 Nov 2024273.6
04 Nov 2024275.75
01 Nov 2024281.85
31 Oct 2024268.4
30 Oct 2024252.35
29 Oct 2024250.85
28 Oct 2024246.4
25 Oct 2024244.4

SWOT Analysis Of Piramal Pharma Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Piramal Pharma Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Piramal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Piramal Pharma Ltd

No data available

No data available

Historical P/E Ratio of Piramal Pharma Ltd

No data available

* All values are in %

Historical Revenue of Piramal Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Piramal Pharma Ltd

No data available

* All values are in crore

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

DIVIDENDPAYOUT

₹ -

Last updated on: Jul 12, 2024

About Piramal Pharma Ltd

  • Piramal Pharma Limited was incorporated on March 4, 2020 as a Public Limited Company and registered with the RoC. The Company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 17 global facilities and a global distribution network in over 100 countries.
  • It includes an integrated CDMO business, CHG business and ICH business, selling over-the-counter products in India.
  • In addition, it has a joint venture with Allergan, a leader in ophthalmology in the Indian formulations market. Piramal Pharma Solution provides integrated drug discovery, development, and manufacturing services for both drug substances, i.e. active pharmaceutical ingredients (APIs) and drug products, i.e. formulations across the life cycle of a molecule, from discovery and clinical development to commercial launch.

Piramal Pharma Ltd News Hub

News

Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT

Revenue from operations grew by 17.28% year on year (YoY) to Rs 2,241.75 crore during the ...

Read more

24 Oct 202412:32

News

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October ...

Read more

15 Oct 202410:20

News

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Or...

Read more

30 Sep 202418:48

News

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets ini...

Read more

17 Sep 202410:14

News

Piramal Pharma grants 48.30 lakh stock options

Piramal Pharma has granted 48,30,836 stock options under Employee Stock Option and Incenti...

Read more

26 Jul 202410:05

News

Piramal Pharma Q1 net loss narrows to Rs 89 crore

Revenue from operations grew by 11.57% year on year (YoY) to Rs 1,951.14 crore during the ...

Read more

26 Jul 202414:28

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Piramal Pharma Ltd Market Cap

What is the market cap of Piramal Pharma Ltd?

As of November 8, 2024, Piramal Pharma Ltd has a market capitalization of ₹38725.1, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Piramal Pharma Ltd's market capitalization?

Piramal Pharma Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Piramal Pharma Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Piramal Pharma Ltd's market capitalization change?

Piramal Pharma Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*